연구

연구업적

최근 5년 연구업적 현황
연도 2025년 2024년 2023년 2022년 2021년
SCI 논문
발표편수
책임 196편 179편 173편 163편 184편
공동 132편 147편 120편 115편 136편
합계 328편 326편 293편 278편 320편
1745. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
Namkung J(1), Kwon W(2,)(3), Choi Y(1), Yi SG(1), Han S(1), Kang MJ(2), Kim SW(2), Park T(4), Jang JY(2).
J Gastroenterol Hepatol.?2015 Dec 8. doi: 10.1111/jgh. Link
1744. Clinicopathologic Differences in Patients with Gallbladder Cancer According to the Presence of Anomalous Biliopancreatic Junction.
Chang J(1), Jang JY(2), Kang MJ(2), Jung W(2), Shin YC(2), Kim SW(3).
World J Surg. 2015 Dec 2. Link
1743. Biomarker Development for Intraductal Papillary Mucinous Neoplasms Using Multiple Reaction Monitoring Mass Spectrometry.
Kim Y(1,)(2), Kang M(1,)(2), Han D(1,)(2), Kim H(1,)(2), Lee K(1,)(2), Kim SW(1,)(2), Kim Y(1,)(2), Park T(1,)(2), Jang JY(1,)(2), Kim Y(1,)(2).
J Proteome Res. 2015 Nov 24. Link
1742. Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer.
Jung W(1), Jang JY(1), Kang MJ(1), Chang YR(1), Shin YC(1), Chang J(1), Kim SW(1)
Gut Liver. 2016 Jan 23;10(1):140-6 Link
1741. Endocrine Function Impairment After Distal Pancreatectomy: Incidence and Related Factors.
Kang JS(1), Jang JY(2), Kang MJ(1), Kim E(1), Jung W(1), Chang J(1), Shin Y(1), Han Y(1), Kim SW(1).
World J Surg. 2015 Sep 2. Link
1740. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas
Kim JR(1), Jang JY(1), Kang MJ(1), Park T(2), Lee SY(3), Jung W(1), Chang J(1), Shin Y(1), Han Y(1), Kim SW(1).
J Hepatobiliary Pancreat Sci. 2015 Sep;22(9):699-707. Link
1739. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ(1), Jang JY, Lee S, Park T, Lee SY, Kim SW.
World J Surg. 2015 Aug;39(8):2006-13. Link
1738. Suggestions for Improving Perihilar Cholangiocarcinoma Staging Based on an Evaluation of the Seventh Edition AJCC System.
Kwon W(1), Jang JY, Chang YR, Jung W, Kang MJ, Kim SW.
J Gastrointest Surg. 2015 Apr;19(4):666-74 Link
1737. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A, Im SA, Kim DK, Song SH, Kim HJ, Lee KH, Kim TY, Han SW, Oh DY, Kim TY, O'Connor MJ, Bang YJ.
Breast Cancer Res. 2015 Mar 7;17:33. Link
1736. A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer.
Kim JW, Choi IS, Kim YJ, Lee KH, Lee KW, Kim TY, Han SW, Kim JH, Kim TY, Lee JS, Bang YJ,?Im SA, Oh DY.
Cancer Chemother Pharmacol. 2015 Jun;75(6):1175-82. Link